TY - JOUR
T1 - Regulation of a distinct activated RIPK1 intermediate bridging complex I and complex II in TNFα-mediated apoptosis
AU - Amin, Palak
AU - Florez, Marcus
AU - Najafov, Ayaz
AU - Pan, Heling
AU - Geng, Jiefei
AU - Ofengeim, Dimitry
AU - Dziedzic, Slawomir A.
AU - Wang, Huibing
AU - Barrett, Vica Jean
AU - Ito, Yasushi
AU - LaVoie, Matthew J.
AU - Yuan, Junying
N1 - Funding Information:
ACKNOWLEDGMENTS. This work was supported by National Institute of Neurological Disorders and Stroke Grant 1R01NS082257, National Institute on Aging (NIA) Grants 1R01AG047231 and RF1AG055521, and NIH Grant T32 GM007306 and NIH/NIA Grant T32 AG000222 (to P.A.).
Funding Information:
This work was supported by National Institute of Neurological Disorders and Stroke Grant 1R01NS082257, National Institute on Aging (NIA) Grants 1R01AG047231 and RF1AG055521, and NIH Grant T32 GM007306 and NIH/NIA Grant T32 AG000222 (to P.A.).
Publisher Copyright:
© 2018 National Academy of Sciences. All Rights Reserved.
PY - 2018/6/26
Y1 - 2018/6/26
N2 - Stimulation of cells with TNFα can promote distinct cell death pathways, including RIPK1-independent apoptosis, necroptosis, and RIPK1-dependent apoptosis (RDA)—the latter of which we still know little about. Here we show that RDA involves the rapid formation of a distinct detergent-insoluble, highly ubiquitinated, and activated RIPK1 pool, termed “iuRIPK1.” iuRIPK1 forms after RIPK1 activation in TNF-receptor-associated complex I, and before cytosolic complex II formation and caspase activation. To identify regulators of iuRIPK1 formation and RIPK1 activation in RDA, we conducted a targeted siRNA screen of 1,288 genes. We found that NEK1, whose loss-of-function mutations have been identified in 3% of ALS patients, binds to activated RIPK1 and restricts RDA by negatively regulating formation of iuRIPK1, while LRRK2, a kinase implicated in Parkinson’s disease, promotes RIPK1 activation and association with complex I in RDA. Further, the E3 ligases APC11 and c-Cbl promote RDA, and c-Cbl is recruited to complex I in RDA, where it promotes prodeath K63-ubiquitination of RIPK1 to lead to iuRIPK1 formation. Finally, we show that two different modes of necroptosis induction by TNFα exist which are differentially regulated by iuRIPK1 formation. Overall, this work reveals a distinct mechanism of RIPK1 activation that mediates the signaling mechanism of RDA as well as a type of necroptosis.
AB - Stimulation of cells with TNFα can promote distinct cell death pathways, including RIPK1-independent apoptosis, necroptosis, and RIPK1-dependent apoptosis (RDA)—the latter of which we still know little about. Here we show that RDA involves the rapid formation of a distinct detergent-insoluble, highly ubiquitinated, and activated RIPK1 pool, termed “iuRIPK1.” iuRIPK1 forms after RIPK1 activation in TNF-receptor-associated complex I, and before cytosolic complex II formation and caspase activation. To identify regulators of iuRIPK1 formation and RIPK1 activation in RDA, we conducted a targeted siRNA screen of 1,288 genes. We found that NEK1, whose loss-of-function mutations have been identified in 3% of ALS patients, binds to activated RIPK1 and restricts RDA by negatively regulating formation of iuRIPK1, while LRRK2, a kinase implicated in Parkinson’s disease, promotes RIPK1 activation and association with complex I in RDA. Further, the E3 ligases APC11 and c-Cbl promote RDA, and c-Cbl is recruited to complex I in RDA, where it promotes prodeath K63-ubiquitination of RIPK1 to lead to iuRIPK1 formation. Finally, we show that two different modes of necroptosis induction by TNFα exist which are differentially regulated by iuRIPK1 formation. Overall, this work reveals a distinct mechanism of RIPK1 activation that mediates the signaling mechanism of RDA as well as a type of necroptosis.
KW - Apoptosis
KW - Necroptosis
KW - RIPK1
KW - TNF
KW - Ubiquitination
UR - http://www.scopus.com/inward/record.url?scp=85049008712&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85049008712&partnerID=8YFLogxK
U2 - 10.1073/pnas.1806973115
DO - 10.1073/pnas.1806973115
M3 - Article
C2 - 29891719
AN - SCOPUS:85049008712
SN - 0027-8424
VL - 115
SP - E5944-E5953
JO - Proceedings of the National Academy of Sciences of the United States of America
JF - Proceedings of the National Academy of Sciences of the United States of America
IS - 26
ER -